+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project



Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project



Rheumatology 56(9): 1472-1478



To assess the 10-year cardiovascular (CV) risk score and to identify treatment and undertreatment of CV risk factors in patients with established RA. Demographics, CV risk factors and prevalence of cardiovascular disease (CVD) were assessed by questionnaire. To calculate the 10-year CV risk score according to the Dutch CV risk management guideline, systolic blood pressure was measured and cholesterol levels were determined from fasting blood samples. Patients were categorized into four groups: indication for treatment but not treated; inadequately treated, so not meeting goals (systolic blood pressure ⩽140 mmHg and/or low-density lipoprotein ⩽2.5 mmol/l); adequately treated; or no treatment necessary. A total of 720 consecutive RA patients were included, 375 from Reade and 345 from the Antonius Hospital. The mean age of patients was 59 years (s.d. 12) and 73% were female. Seventeen per cent of the patients had a low 10-year CV risk (<10%), 21% had an intermediate risk (10-19%), 53% a high risk (⩾20%) and 9% had CVD. In total, 69% had an indication for preventive treatment (cholesterol-lowering or antihypertensive drugs). Of those, 42% received inadequate treatment and 40% received no treatment at all. Optimal CV risk management remains a major challenge and better awareness and management are urgently needed to reduce the high risk of CVD in the RA population.

(PDF emailed within 0-6 h: $19.90)

Accession: 059472108

Download citation: RISBibTeXText

PMID: 28199724

DOI: 10.1093/rheumatology/kew497


Related references

Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Research and Therapy 14(6): R270, 2015

OP0314Is Cardiovascular Risk Management in Patients with Rheumatoid Arthritis Effective? Two Year Follow Up Reveals Unexpected Rise in Cardiovascular Risk!. Annals of the Rheumatic Diseases 74(Suppl 2): 192.1-192, 2015

Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management. Clinical Rheumatology 36(6): 1387-1393, 2017

Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. Rheumatology 56(5): 777-786, 2017

Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care. Annals of the Rheumatic Diseases 77(4): 480-483, 2017

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 69(2): 325-331, 2010

Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Annals of the Rheumatic Diseases 70(5): 719-721, 2011

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?. Annals of the Rheumatic Diseases 67(1): 64-69, 2007

Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study. Arthritis Care and Research 69(1): 51-57, 2016

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Therapeutic Advances in Musculoskeletal Disease 5(4): 166-181, 2013

Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis. Zhonghua Xin Xue Guan Bing Za Zhi 43(4): 374-376, 2016

Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care and Research 68(5): 629-637, 2017

Vitamin D replacement therapy: a promising adjunct in cardiovascular risk management among patients with rheumatoid arthritis?. Journal of Rheumatology 40(9): 1463-1465, 2014

Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: the "EPIDAURO registry". International Journal of Cardiology 172(2): 534-536, 2015

THU0108Closing The Audit Cycle: Have Cardiovascular Risk Assessment and Management in Rheumatoid Arthritis Patients Improved?. Annals of the Rheumatic Diseases 75(Suppl 2): 218.3-219, 2016